Canada Vigilance Program - Collecting and Assessing Adverse Reaction Reports

The Canada Vigilance Program collects and assesses reports of suspected adverse reactions to marketed health products in Canada, including prescription and non-prescription medications; natural health products; biologically derived products such as vaccines and fractionated blood products; cells, tissues and organs; radiopharmaceuticals; and disinfectants and sanitizers with disinfectant claims.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification janvier 20, 2026, 00:32 (TU)
Créé le janvier 16, 2026, 20:36 (TU)
crisis_categories Événements climatiques extrêmes
criticality_level Élevé
data_formats HTML
description_fr The Canada Vigilance Program collects and assesses reports of suspected adverse reactions to marketed health products in Canada, including prescription and non-prescription medications; natural health products; biologically derived products such as vaccines and fractionated blood products; cells, tissues and organs; radiopharmaceuticals; and disinfectants and sanitizers with disinfectant claims.
fair_openness Level 2 - Machine-readable
geographic_scope Canada
opening_level Donnée ouverte au grand public
sector health_and_safety
sensitivity_level Faible
source_inventaire Inventaire_F
source_url https://geoegl.msp.gouv.qc.ca/igo2/apercu-qc/?context=avp
title_fr Canada Vigilance Program - Collecting and Assessing Adverse Reaction Reports
update_frequency Selon les besoins